Skip to main content
Fig. 7 | Biomaterials Research

Fig. 7

From: Bionic natural small molecule co-assemblies towards targeted and synergistic Chemo/PDT/CDT

Fig. 7

In vivo bio-distribution and cancer therapeutic efficacy of CM@OABACe6/Cu NPs. Imaging was performed at different time points after i.v. injection of CM@OABACe6/Cu NPs and free Ce6. a The overall timetable for animal experiments. b In vivo fluorescence imaging of 4T1 tumor-bearing mice, c Average fluorescence intensity of 4T1 tumor-bearing mice. d FL images of tumors and major organs (H: heart, Lu: lung, Li: liver, S: spleen, and K: kidneys) excised from mice after i.v., and e) average fluorescence intensity. f Changes in body weight of tumor-bearing mice in different treatment groups. g Tumor growth curves in different treatment groups during the monitoring period. h) Tumor suppression rates of mice in different treatment groups after 14 days (*p < 0.05 and **p < 0.01). i Photographs of dissected tumor tissues of each treatment group after 14 days

Back to article page